Related Experiment Video
Updated: Jan 7, 2026

An In Ovo Model for Testing Insulin-mimetic Compounds
Published on: April 23, 2018
Synthesis of non-steroidal cholic acid analogues as potent and selective TGR5 allosteric agonists with antidiabetic
Xinyan Shen1, Xuemei Shao1, Bowei Dong1
1School of Pharmacy, Changzhou University, Changzhou 213164, PR China.
Abstract:
In this study, we designed and synthesized 12 novel non-steroidal cholic acid (CA) analogues as potential Takeda G protein coupled receptor 5 (TGR5) allosteric agonists based on scaffold hopping strategy. Biological results showed that all final compounds were able to activate the receptor both in human TGR5 (hTGR5) and mouse TGR5 (mTGR5) by Glosensor cAMP accumulation assay. Remarkably, lactone A1 and lactam A10 displayed 48- and 24-fold higher potencies than that of CA in hTGR5 cAMP accumulation, respectively. Furthermore, target compounds exhibited higher selectivity for cAMP formation compared to β-arrestin2 recruitment. Interestingly, target compounds A1-10 positively modulated the functional activity and potency of lithocholic acid (LCA) in TGR5, indicating that A1-10 are TGR5 allosteric agonists. Molecular docking study displayed that both lactone in A5 and lactam in A10 formed H-bonds with the key amino acid residue Thr131, which are critical for TGR5 allosteric effect. Unexpectedly, none of target compounds A1-10 could activate farnesoid X receptor (FXR), indicating that final compounds are potent and selective TGR5 allosteric agonists. More importantly, both A1 and A10 exhibited significant glucose-lowering effects in the oral glucose tolerance test (OGTT) in mice. Taken together, we discovered two potent and selective TGR5 allosteric agonists A1 and A10, which could be employed as lead compounds to further study TGR5 allostery with potential antidiabetic effects.
Related Concept Videos
Glucagon-like Receptor Agonists
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
Oral Hypoglycemic Agents: α-Glucosidase Inhibitors
Acarbose and miglitol are...
Direct-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship
The direct-acting...
Direct-Acting Cholinergic Agonists: Pharmacokinetics
Cholinergic Antagonists: Chemistry and Structure-Activity Relationship
Indirect-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship
Reversible inhibitors display short to medium durations of action. Short-acting agents include simple alcohols with...